Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Vijaypd Ceutical Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹35
Per ShareLot Size
4000 Shares
Minimum Investment
₹1,40,000
Issue Size
₹19.25 Cr
Face Value
₹10
Per ShareIPO Type
Fixed Price - SME
Retail Quota
50%
QIB Quota
0%
NII Quota
50%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
78.3%
Promoter Holding (Post-Issue)
56.25%
Issue Type
Fixed Price - SME
ISIN
INE0WL901019
We are engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Our roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. We offer a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Our pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. We also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits. In the FMCG segment, we provide personal care and toiletry products, including soaps, sanitizers, and baby care items. Additionally, we deal in ayurvedic products, cosmetics, food products, dental products, and crude drugs.
Indian pharmaceutical industry is ranked as the third largest in the world, in terms of volumes of drugs manufactured and thirteenth largest, in terms of value. The Country is also the world's largest supplier of cost-effective generic drugs, and accounts for nearly one fifth of the global trade in generic drugs. India has achieved an enviable position in global generic drug market on the back of its strength in organic chemical synthesis and process engineering. Indian pharmaceutical industry, which followed process patent structure for close to 30 years till the amendment of Patent Act in 2005 was favorable for generic drug manufacturers. The process patent structure allowed industry to launch low-cost alternatives to innovator drugs, if the manufacturing process was different. India with its technically skilled labor force was able to reverse engineer patented drugs and hence became one of the largest and most developed generic drug markets in the world.
Revenue, profit after tax and total assets for the last reported financial year.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offer of 55,00,000 equity shares of face value of Rs. 10/- each (the "Equity Shares") of Vijaypd Ceutical Limited ("the Company" or "Vijaypd" or "the Issuer") for cash at a price of Rs.35/- per equity share including a share premium of Rs.25/- per equity share (the "Issue Price") aggregating to Rs.19.25 crores ("the Issue"), of which 2,84,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 35/- per equity share including a share premium of Rs. 25/- per equity share aggregating to Rs. 0.99 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e., net issue of 52,16,000 equity shares of face value of Rs. 10/- each at a price of Rs. 35/- per equity share including a share premium of Rs. 25/- per equity share aggregating to Rs. 18.26 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 28.16% and 26.71% respectively of the post issue paid up equity share capital of the company. Price Band: Rs. 35/- for equity share of face value of Rs. 10 each. The floor price is 3.50 times times the face value times of the face value of the equity shares. Bids can made for a minimum of 8,000 equity shares and in multiples of 4,000 equity shares thereafter.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Our Company was originally formed as a partnership firm under the name and style of "Vijay Pharma" pursuant to a deed of partnership dated October 05, 1971, as amended from time to time. Further, Vijay Pharma was converted into a public limited company "VijayPD Ceutical Limited" pursuant to the provisions of Chapter XXI of the Companies Act, 2013 and a fresh Certificate of Incorporation dated March 19, 2024, was issued by Assistant Registrar of Companies, Central Registration Centre. Further our Company has acquired the running business of P.D. Doshi, a Partnership firm on going concern basis vide Business Transfer Agreement dated April 01, 2024 entered by and between Samit Madhukar Shah, Rahul Jitendra Shah, Jigar Narendra Shah, Bhavin Dhirendra Shah, Dhirendra Chimanlal Shah and Nila Narendra Shah, on behalf of P.D. Doshi, Partnership firm and our company. The Corporate Identification Number of our Company is U21001MH2024PLC421713.
Wholesaler and Retailer
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY26.